Condition | Indicated | Relationship Strength | Studies | Trials |
Malignant Mesothelioma [description not available] | 0 | 9.59 | 8 | 0 |
Cancer of Lung [description not available] | 0 | 9.29 | 49 | 1 |
Lung Neoplasms Tumors or cancer of the LUNG. | 0 | 9.29 | 49 | 1 |
Mesothelioma A tumor derived from mesothelial tissue (peritoneum, pleura, pericardium). It appears as broad sheets of cells, with some regions containing spindle-shaped, sarcoma-like cells and other regions showing adenomatous patterns. Pleural mesotheliomas have been linked to exposure to asbestos. (Dorland, 27th ed) | 0 | 8.34 | 77 | 0 |
Cancer of Ovary [description not available] | 0 | 2.25 | 1 | 0 |
Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. | 0 | 2.25 | 1 | 0 |
Diseases, Occupational [description not available] | 0 | 8.29 | 37 | 0 |
Neoplasms, Pleural [description not available] | 0 | 6.5 | 32 | 0 |
Asbestosis A form of pneumoconiosis caused by inhalation of asbestos fibers which elicit potent inflammatory responses in the parenchyma of the lung. The disease is characterized by interstitial fibrosis of the lung, varying from scattered sites to extensive scarring of the alveolar interstitium. | 0 | 7.16 | 34 | 1 |
Autoimmune Disease [description not available] | 0 | 2.5 | 2 | 0 |
Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. | 0 | 2.5 | 2 | 0 |
Innate Inflammatory Response [description not available] | 0 | 2.78 | 3 | 0 |
Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 2.78 | 3 | 0 |
Peritoneal Carcinomatosis [description not available] | 0 | 3.39 | 7 | 0 |
Peritoneal Neoplasms Tumors or cancer of the PERITONEUM. | 0 | 3.39 | 7 | 0 |
Breast Cancer [description not available] | 0 | 7.08 | 1 | 0 |
Breast Neoplasms Tumors or cancer of the human BREAST. | 0 | 2.08 | 1 | 0 |
Diseases of Immune System [description not available] | 0 | 2.1 | 1 | 0 |
Diseases, Metabolic [description not available] | 0 | 2.1 | 1 | 0 |
Benign Neoplasms [description not available] | 0 | 2.71 | 3 | 0 |
Immune System Diseases Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both. | 0 | 2.1 | 1 | 0 |
Metabolic Diseases Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed) | 0 | 2.1 | 1 | 0 |
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 0 | 2.71 | 3 | 0 |
Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. | 0 | 2.42 | 2 | 0 |
Pleural Effusion Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. | 0 | 3.32 | 2 | 0 |
Bronchial Hyperreactivity Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory. | 0 | 2.13 | 1 | 0 |
Adenocarcinoma, Alveolar [description not available] | 0 | 2.41 | 2 | 0 |
Adenocarcinoma, Bronchiolo-Alveolar A carcinoma derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. (From Stedman, 25th ed) | 0 | 2.41 | 2 | 0 |
Bagassosis A diffuse parenchymal lung disease caused by inhaled dust from processing SUGARCANE (bagasse), usually in the manufacturing of wallboard. | 0 | 3.98 | 5 | 0 |
Pneumoconiosis A diffuse parenchymal lung disease caused by inhalation of dust and by tissue reaction to their presence. These inorganic, organic, particulate, or vaporized matters usually are inhaled by workers in their occupational environment, leading to the various forms (ASBESTOSIS; BYSSINOSIS; and others). Similar air pollution can also have deleterious effects on the general population. | 0 | 3.98 | 5 | 0 |
Pleural Diseases Diseases involving the PLEURA. | 0 | 5.15 | 18 | 0 |
Necrosis The death of cells in an organ or tissue due to disease, injury or failure of the blood supply. | 0 | 2.08 | 1 | 0 |
Alveolitis, Fibrosing [description not available] | 0 | 4.51 | 9 | 0 |
Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. | 0 | 4.51 | 9 | 0 |
Respiratory Tract Diseases Diseases involving the RESPIRATORY SYSTEM. | 0 | 2.69 | 3 | 0 |
Calcification, Pathologic [description not available] | 0 | 3.49 | 8 | 0 |
Calcinosis Pathologic deposition of calcium salts in tissues. | 0 | 3.49 | 8 | 0 |
Disease Exacerbation [description not available] | 0 | 2.43 | 2 | 0 |
Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. | 0 | 2.39 | 2 | 0 |
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 3.36 | 2 | 0 |
Cancer of Gastrointestinal Tract [description not available] | 0 | 2.39 | 2 | 0 |
Experimental Neoplasms [description not available] | 0 | 2.36 | 2 | 0 |
Cancer of Kidney [description not available] | 0 | 1.96 | 1 | 0 |
Experimental Leukemia [description not available] | 0 | 1.96 | 1 | 0 |
Cancer of Liver [description not available] | 0 | 1.96 | 1 | 0 |
Cancer of the Thyroid [description not available] | 0 | 1.96 | 1 | 0 |
Cocarcinogenesis The combination of two or more different factors in the production of cancer. | 0 | 1.96 | 1 | 0 |
Kidney Neoplasms Tumors or cancers of the KIDNEY. | 0 | 1.96 | 1 | 0 |
Liver Neoplasms Tumors or cancer of the LIVER. | 0 | 1.96 | 1 | 0 |
Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. | 0 | 1.96 | 1 | 0 |
Canine Diseases [description not available] | 0 | 1.98 | 1 | 0 |
Caprine Diseases [description not available] | 0 | 1.98 | 1 | 0 |
Abnormalities, Autosome [description not available] | 0 | 2.38 | 2 | 0 |
Cardiac Cancer [description not available] | 0 | 1.98 | 1 | 0 |
Synovioma [description not available] | 0 | 1.98 | 1 | 0 |
Chromosomal Translocation [description not available] | 0 | 1.98 | 1 | 0 |
Sarcoma, Synovial A malignant neoplasm arising from tenosynovial tissue of the joints and in synovial cells of tendons and bursae. The legs are the most common site, but the tumor can occur in the abdominal wall and other trunk muscles. There are two recognized types: the monophasic (characterized by sheaths of monotonous spindle cells) and the biphasic (characterized by slit-like spaces or clefts within the tumor, lined by cuboidal or tall columnar epithelial cells). These sarcomas occur most commonly in the second and fourth decades of life. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1363) | 0 | 1.98 | 1 | 0 |
Fibromatosis [description not available] | 0 | 1.99 | 1 | 0 |
Local Neoplasm Recurrence [description not available] | 0 | 1.99 | 1 | 0 |
Fibroma A benign tumor of fibrous or fully developed connective tissue. | 0 | 1.99 | 1 | 0 |
Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) | 0 | 1.99 | 1 | 0 |
Respiratory Tract Neoplasms New abnormal growth of tissue in the RESPIRATORY SYSTEM. | 0 | 2.38 | 2 | 0 |
Obstructive Lung Diseases [description not available] | 0 | 2 | 1 | 0 |
Lung Diseases, Obstructive Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent. | 0 | 2 | 1 | 0 |
Lymphocytosis Excess of normal lymphocytes in the blood or in any effusion. | 0 | 2.01 | 1 | 0 |
Aneuploid [description not available] | 0 | 1.98 | 1 | 0 |
Sarcoma, Epithelioid [description not available] | 0 | 1.97 | 1 | 0 |
Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant. | 0 | 1.97 | 1 | 0 |
Disease, Pulmonary [description not available] | 0 | 3.07 | 5 | 0 |
Lung Diseases Pathological processes involving any part of the LUNG. | 0 | 3.07 | 5 | 0 |
Granuloma, Hodgkin [description not available] | 0 | 1.97 | 1 | 0 |
Cancer of Stomach [description not available] | 0 | 1.97 | 1 | 0 |
Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. | 0 | 1.97 | 1 | 0 |
Stomach Neoplasms Tumors or cancer of the STOMACH. | 0 | 1.97 | 1 | 0 |